Hepatic Overlap Syndrome Improved With Infliximab.
作者信息
Hilzenrat Nir, Lamoureux Esther, Cohen Albert, Baron Murray
机构信息
SMBD- Jewish General Hospital, McGill University, Montreal.
出版信息
Gastroenterol Hepatol (N Y). 2006 Feb;2(2):88-90.
Abstract
摘要
相似文献
1
Hepatic Overlap Syndrome Improved With Infliximab.英夫利昔单抗改善肝重叠综合征。
Gastroenterol Hepatol (N Y). 2006 Feb;2(2):88-90.
2
[A case in which the subject was affected by Listeia meningoencephalitis during administration of infliximab for steroid-dependent adult onset Still's disease].[1例在使用英夫利昔单抗治疗类固醇依赖型成人斯蒂尔病期间发生李斯特菌性脑膜脑炎的病例]
Nihon Rinsho Meneki Gakkai Kaishi. 2006 Jun;29(3):160-8. doi: 10.2177/jsci.29.160.
3
A lupus-like syndrome associated with infliximab therapy.一种与英夫利昔单抗治疗相关的狼疮样综合征。
Inflamm Bowel Dis. 2003 May;9(3):176-8. doi: 10.1097/00054725-200305000-00005.
4
Coexistent psoriasis and lupus erythematosus treated with alefacept.用阿法赛特治疗并存的银屑病和红斑狼疮。
Am J Clin Dermatol. 2007;8(1):47-50. doi: 10.2165/00128071-200708010-00007.
5
The effect of infliximab on hepatic cytochrome P450 and pharmacokinetics of verapamil in rats with pre-adjuvant arthritis: a drug-disease and drug-drug interaction.英夫利昔单抗对佐剂性关节炎大鼠肝脏细胞色素P450及维拉帕米药代动力学的影响：药物-疾病及药物-药物相互作用
Basic Clin Pharmacol Toxicol. 2009 Jul;105(1):24-9. doi: 10.1111/j.1742-7843.2009.00405.x. Epub 2009 Apr 3.
6
Prednisolone but not infliximab aggravates the upregulated hepatic nitrogen elimination in patients with active inflammatory bowel disease.泼尼松龙而非英夫利昔单抗加重活动期炎症性肠病患者肝氮消除上调。
Inflamm Bowel Dis. 2014 Jan;20(1):7-13. doi: 10.1097/01.MIB.0000437496.07181.4c.
7
Pregnancy-Induced Sweet's Syndrome Treated with Infliximab.妊娠相关性Sweet 综合征应用英夫利昔单抗治疗。
Med Princ Pract. 2019;28(2):196-198. doi: 10.1159/000494974. Epub 2018 Oct 30.
8
Infliximab monotherapy for severe alcoholic hepatitis and predictors of survival: an open label trial.英夫利昔单抗单药治疗重症酒精性肝炎及生存预测因素：一项开放标签试验。
J Hepatol. 2009 Mar;50(3):584-91. doi: 10.1016/j.jhep.2008.10.024. Epub 2008 Dec 25.
9
Infliximab-induced hepatitis: absence of cross-toxicity with etanercept.英夫利昔单抗诱导的肝炎：与依那西普无交叉毒性。
Joint Bone Spine. 2008 Dec;75(6):737-9. doi: 10.1016/j.jbspin.2007.12.009. Epub 2008 Aug 6.
10
Nonalcoholic steatohepatitis as a novel player in metabolic syndrome-induced erectile dysfunction: an experimental study in the rabbit.非酒精性脂肪性肝炎作为代谢综合征所致勃起功能障碍的新因素：一项在兔子身上的实验研究
Mol Cell Endocrinol. 2014 Mar 25;384(1-2):143-54. doi: 10.1016/j.mce.2014.01.014. Epub 2014 Jan 31.
引用本文的文献
1
Review.综述
Gastroenterol Hepatol (N Y). 2007 Jun;3(6):453-4.
本文引用的文献
1
Expression of cytokines (TNF-alpha, IL-1alpha, and IL-2) in chronic hepatitis C: comparative hybridocytochemical and immunocytochemical study in children and adult patients.
J Histochem Cytochem. 2004 Jan;52(1):29-38. doi: 10.1177/002215540405200104.
2
Effect of tumour necrosis factor alpha antagonists on serum transaminases and viraemia in patients with rheumatoid arthritis and chronic hepatitis C infection.肿瘤坏死因子α拮抗剂对类风湿性关节炎合并慢性丙型肝炎感染患者血清转氨酶及病毒血症的影响。
Ann Rheum Dis. 2003 Nov;62(11):1078-82. doi: 10.1136/ard.62.11.1078.
3
Effects of proinflammatory cytokines on rat organic anion transporters during toxic liver injury and cholestasis.促炎细胞因子对大鼠中毒性肝损伤和胆汁淤积期间有机阴离子转运体的影响。
Hepatology. 2003 Aug;38(2):345-54. doi: 10.1053/jhep.2003.50317.
4
Tumour necrosis factor alpha is an important mediator of portal and systemic haemodynamic derangements in alcoholic hepatitis.肿瘤坏死因子α是酒精性肝炎中门静脉和全身血流动力学紊乱的重要介质。
Gut. 2003 Aug;52(8):1182-7. doi: 10.1136/gut.52.8.1182.
5
Review article: the expanding role of biological agents in the treatment of inflammatory bowel disease - focus on selective adhesion molecule inhibition.综述文章：生物制剂在炎症性肠病治疗中不断扩大的作用——聚焦于选择性黏附分子抑制
Aliment Pharmacol Ther. 2003 Jun 15;17(12):1435-50. doi: 10.1046/j.1365-2036.2003.01603.x.
6
Anti-tumor necrosis factor-alpha monoclonal antibody therapy in severe alcoholic hepatitis.抗肿瘤坏死因子-α单克隆抗体疗法治疗严重酒精性肝炎
J Hepatol. 2003 Apr;38(4):419-25. doi: 10.1016/s0168-8278(02)00442-7.
7
Improvement in cholestasis associated with total parenteral nutrition after treatment with an antibody against tumour necrosis factor alpha.
Liver. 2002 Aug;22(4):317-20. doi: 10.1034/j.1600-0676.2002.01649.x.
8
Tumor necrosis factor-alpha and transforming growth factor-beta reflect severity of liver damage in primary biliary cirrhosis.肿瘤坏死因子-α和转化生长因子-β反映原发性胆汁性肝硬化肝损伤的严重程度。
J Gastroenterol Hepatol. 2002 Feb;17(2):196-202. doi: 10.1046/j.1440-1746.2002.02672.x.
9
The role of tumor necrosis factor-alpha in liver toxicity, inflammation, and fibrosis induced by carbon tetrachloride.肿瘤坏死因子-α在四氯化碳诱导的肝毒性、炎症和纤维化中的作用。
Toxicol Appl Pharmacol. 2001 Dec 1;177(2):112-20. doi: 10.1006/taap.2001.9304.
10
Cytokines and liver diseases.细胞因子与肝脏疾病
Can J Gastroenterol. 2001 Oct;15(10):661-8. doi: 10.1155/2001/746736.
Zotero 插件